9amHealth, an AI-enabled virtual specialty care startup, raised $26 million in a Series B funding round led by Define Ventures, with participation from SemperVirens VC, Catalio Capital Management, and NewHealth Ventures.
Including the latest investment, 9amHealth has raised approximately $56 million across multiple funding rounds since its founding in 2021.
9amHealth said the new funding will support continued growth as the company expands its platform to address additional high-cost, specialty-level chronic conditions, which collectively account for up to 70% of employer pharmacy spend.
9amHealth, based in San Diego, California, partners with employers, health plans, and pharmacy benefit managers to deliver comprehensive, cost-effective medical care for individuals living with obesity, diabetes, hypertension, and dyslipidemia. Members receive access to specialized clinicians, including endocrinologists, obesity medicine specialists, and clinical pharmacists, at-home lab testing, prescription medications, and lifestyle support.
“What makes this possible is our ability to combine specialized clinical care with AI-enabled clinical workflows and personalized member experiences that allow us to scale efficiently across complex chronic conditions,” said Frank Westermann, CEO and Co-Founder of 9amHealth. “We’ve already proven this model in cardiometabolic care, and are now extending to a much broader set of high-cost needs.”
The Series B round was led by Lynne O’Keefe, Founder and Managing Partner at Define Ventures, who will join the company’s Board of Directors.
Digital health companies, including AI-powered specialized virtual care startups, have secured more than $180 billion in funding to date, according to our recent 2026 Funding Database. Notable recent funding rounds include:
- Tava Health, a provider of hybrid (online and in-person) mental health care services for a range of conditions, including addiction, depression, eating disorders, and stress, raised $40 million in a Series C funding round.
- Zócalo Health, a provider of AI-powered virtual primary care for Latino patients, raised $15 million in Series A funding.
- Remission Medical, a virtual rheumatology startup addressing a range of rheumatological conditions, including rheumatoid arthritis, osteoporosis, osteoarthritis, lupus, and gout, among others, raised a Series A funding round led by Blue Heron Capital.
- Los Angeles-based startup Village (village.health), an AI-powered pediatric care platform, has raised $9.5 million in an equity funding round to scale its AI-enabled, pediatric care network across the U.S. The investment round was led by Upfront Ventures, with participation from Bling Capital, GTMFund, and Perceptive Ventures.